ImCare Biotech has been awarded SBIR grant by NCI (NIH) (National Cancer Institute) to develop its diagonistic kit Seravue® for early detection of liver cancer (HCC and ICC) on 9/2012.
ImCare biotech has signed agreement with Drexel University, College of Medicine and University of California, Irvine, Medical Center to develop Seravue®.
COMPANY EVENTS PRODUCTS
